+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Neurotransmitter"

Cannabinoid Receptor CB1 Inverse Agonists - Pipeline Insight, 2025 - Product Thumbnail Image

Cannabinoid Receptor CB1 Inverse Agonists - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Spinocerebellar Ataxias - Pipeline Insight, 2025 - Product Thumbnail Image

Spinocerebellar Ataxias - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Lewy Body Disease- Pipeline Insight, 2025 - Product Thumbnail Image

Lewy Body Disease- Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 60 Pages
  • Global
From
Essential Tremor - Pipeline Insight, 2025 - Product Thumbnail Image

Essential Tremor - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 80 Pages
  • Global
From
Subarachnoid Hemorrhage- Pipeline Insight, 2025 - Product Thumbnail Image

Subarachnoid Hemorrhage- Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Brain Hemorrhage - Pipeline Insight, 2025 - Product Thumbnail Image

Brain Hemorrhage - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 75 Pages
  • Global
From
Dementia With Diabetes - Pipeline Insight, 2025 - Product Thumbnail Image

Dementia With Diabetes - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Spasmodic-torticollis - Pipeline Insight, 2025 - Product Thumbnail Image

Spasmodic-torticollis - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 40 Pages
  • Global
From
Gilles De La Tourette's Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Gilles De La Tourette's Syndrome - Pipeline Insight, 2025

  • Drug Pipelines
  • April 2025
  • 40 Pages
  • Global
From
Dystonia - Pipeline Insight, 2025 - Product Thumbnail Image

Dystonia - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
Tourette Syndrome - Pipeline Insight, 2025 - Product Thumbnail Image

Tourette Syndrome - Pipeline Insight, 2025

  • Clinical Trials
  • April 2025
  • 60 Pages
  • Global
From
From
Cognitive and Memory Enhancer Drugs Market 2025-2033 - Product Thumbnail Image

Cognitive and Memory Enhancer Drugs Market 2025-2033

  • Report
  • March 2025
  • 139 Pages
  • Global
From
Memory Disorders Drug Pipeline Analysis Report 2025 - Product Thumbnail Image

Memory Disorders Drug Pipeline Analysis Report 2025

  • Drug Pipelines
  • June 2025
  • 200 Pages
  • Global
From
From
From
From
Sleep Disorders Treatment: Global Market Outlook - Product Thumbnail Image

Sleep Disorders Treatment: Global Market Outlook

  • Report
  • March 2023
  • 57 Pages
  • Global
From
From
From
Loading Indicator

The Neurotransmitter market is a subset of the Central Nervous System Drugs market, which includes drugs used to treat neurological disorders. Neurotransmitters are chemicals that are released by neurons to send signals to other cells. These drugs are used to treat a variety of neurological disorders, including depression, anxiety, and schizophrenia. Neurotransmitter drugs work by either increasing or decreasing the amount of neurotransmitters in the brain. The Neurotransmitter market is highly competitive, with many companies offering a variety of drugs. Some of the major players in the market include Pfizer, GlaxoSmithKline, Eli Lilly, and Merck. Other companies such as Novartis, AstraZeneca, and Johnson & Johnson also have a presence in the Neurotransmitter market. Show Less Read more